drugset / Trial / NCT05856578
Comparing the Efficacy of Mulberry Twig Alkaloid Tablet and Canagliflozin in Patients With Type 2 Diabetes
RandomizedParallel-groupSingle-blindTreatment
Summary
The aim of the study is to investigate the efficacy and safety of Mulberry Twig (Ramulus Mori, Sangzhi) Alkaloid Tablet and Canagliflozin for 12 weeks in individuals with type 2 diabetes mellitus
Timeline
- Start
- 2022-03-15
- Primary completion
- 2023-05-31
- Completion
- 2023-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | CANAGLIFLOZIN ANHYDROUS | Small molecule | 100 mg | Oral |
| Subject | Mulberry Twig (Ramulus Mori, Sangzhi) Alkaloid Tablet 50mg po tid | Unknown | 50 mg | Oral |